Skip to content

Litholytic Therapy for Coral Urate Nephrolithiasis

Litholytic Therapy for Coral Urate Nephrolithiasis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07162974
Enrollment
49
Registered
2025-09-09
Start date
2023-01-01
Completion date
2025-01-09
Last updated
2025-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Brief summary

This is a prospective cohort study, patients with coralloid nephrolithiasis. Purpose of the study: to evaluate the efficacy and safety of litholytic therapy of coral-like urate nephrolithiasis with citrate mixtures.

Detailed description

Anthropometric parameters height and weight were recorded in all patients, body mass index was calculated. All patients underwent MSCT of the urinary tract to assess the volume of density and concrements before the start of therapy. Biochemical blood analysis included determination of creatinine level with subsequent calculation of SCF. Urine pH was monitored for 72 hours using an electronic pH meter before therapy and recorded in a diary by patients three times a day, after which the average pH was calculated. Patients who met the inclusion criteria were included in the study after signing informed consent.

Interventions

DRUGanhydrous citric acid - 1197.0 mg, potassium bicarbonate - 967.5 mg, sodium citrate anhydrous - 835.5 mg

The dosage was selected individually for each patient, the target pH was considered to be 7.2

Sponsors

Moscow State University of Medicine and Dentistry
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

49 patients with coral urate stones.

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Coral-shaped calculus, which fills one or more calyx and pelvis (K2-K4 according to the classification of coral-shaped concretions); * The urate composition of the kidney stone was confirmed using dual-energy MSCT; * Unimpaired or restored (by draining the kidney) urine outflow from the kidney; * Persistently acidic urine pH (pH 5.8 or less); * Stone density is 550 Hounsfield units or less; * Informed voluntary consent of the patient to participate in the study; * Patient's readiness for conservative treatment; * No contraindications to therapy with citrate mixtures;

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the size, volume and density of stones.1 monthComputer tomography is the gold standard for diagnosing urolithiasis; it will allow you to identify stones, determine their size, density, structure, location, and assess the condition of the urinary tract.

Secondary

MeasureTime frameDescription
Kidney function1 monthGlomerular filtration rate (GFR, ml/min/1.73 m2) is a test used to check how well the kidneys are working. Specifically, it estimates how much blood passes through the glomeruli each minute. A GFR of 60 or higher is in the normal range. A GFR below 60 may mean kidney disease. A GFR of 15 or lower may mean kidney failure. The measurement of the glomerular filtration rate will be measured according to the results of the blood test
Assessing the composition of stones6 monthsChemical analysis of stones is a spectrometric (infrared spectroscopy) method that determines its exact composition by analyzing how the stone absorbs infrared radiation. Chemical analysis of stones will be performed on those patients who will undergo surgical treatment.

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026